These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34682388)

  • 1. A Comprehensive Descriptive Epidemiological and Clinical Analysis of SARS-CoV-2 in West-Mexico during COVID-19 Pandemic 2020.
    Viera-Segura O; Vega-Magaña N; García-Chagollán M; Peña-Rodríguez M; Muñoz-Sánchez G; Carranza-Aranda AS; Llamas-Covarrubias IM; Ramos-Solano M; Mora-Mora J; Díaz-Palomera CD; León GE; Zepeda-Nuño JS; Santillán-López E; García-Arellano S; Hernández-Silva CD; Zerpa-Hernandez DA; Muñoz-Rios G; Rodríguez-Sanabria JS; Muñoz-Valle JF
    Int J Environ Res Public Health; 2021 Oct; 18(20):. PubMed ID: 34682388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.
    Peña Rodríguez M; Hernández Bello J; Vega Magaña N; Viera Segura O; García Chagollán M; Ceja Gálvez HR; Mora Mora JC; Rentería Flores FI; García González OP; Muñoz Valle JF
    Front Public Health; 2023; 11():1149795. PubMed ID: 37181688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of symptoms as a diagnostic tool for SARS-CoV 2 infection: a cross-sectional study in a cohort of 2,173 patients.
    Romero-Gameros CA; Colin-Martínez T; Waizel-Haiat S; Vargas-Ortega G; Ferat-Osorio E; Guerrero-Paz JA; Intriago-Alor M; López-Moreno MA; Cuevas-García CF; Mendoza-Zubieta V; Martínez-Ordaz JL; González-Virla B
    BMC Infect Dis; 2021 Mar; 21(1):255. PubMed ID: 33706707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low prevalence of asthma in Mexican children and adults with a positive rtRT-PCR test for SARS-CoV-2: a cross-sectional study during the 2020 pandemic.
    Bedolla-Barajas M; Morales-Romero J; Bedolla-Pulido TR; Meza-López C; Robles-Figueroa M; Pulido-Guillén NA; Orozco-Alatorre LG; Andrade-Castellanos CA
    Allergol Immunopathol (Madr); 2021; 49(3):1-7. PubMed ID: 33938182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
    Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
    BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical-Epidemiological Characteristics of the First Patients Diagnosed with COVID-19 in Cuba.
    Molina-Águila N; Cruz-Rodríguez E; Ferrán-Torres RM; Galindo-Santana BM; López-Almaguer Y; Romero-Placeres M
    MEDICC Rev; 2021 Apr; 23(2):15. PubMed ID: 33974611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of COVID-19 in Mexico: Symptomatic profiles and presymptomatic people.
    Fernández-Rojas MA; Luna-Ruiz Esparza MA; Campos-Romero A; Calva-Espinosa DY; Moreno-Camacho JL; Langle-Martínez AP; García-Gil A; Solís-González CJ; Canizalez-Román A; León-Sicairos N; Alcántar-Fernández J
    Int J Infect Dis; 2021 Mar; 104():572-579. PubMed ID: 33434668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of survival after severe acute respiratory syndrome coronavirus 2 infection in Mexican outpatients and hospitalised patients.
    Prado-Galbarro FJ; Sanchez-Piedra C; Gamiño-Arroyo AE; Cruz-Cruz C
    Public Health; 2020 Dec; 189():66-72. PubMed ID: 33166857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Characterization of SARS-CoV-2 Isolated from Patients with Distinct Disease Outcomes in Mexico.
    Boukadida C; Taboada B; Escalera-Zamudio M; Isa P; Ramírez-González JE; Vazquez-Perez JA; Muñoz-Medina JE; Grajales-Muñiz C; González-Torres C; Gaytán-Cervantes FJ; Rincón-Rubio A; Matías-Florentino M; Esteban Paz-Juárez H; Sanchez-Flores A; Mendieta-Condado E; Barrera-Badillo G; Hernández-Rivas L; López S; López-Martínez I; Ávila-Ríos S; Arias CF
    Microbiol Spectr; 2022 Feb; 10(1):e0124921. PubMed ID: 35019701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 and gastrointestinal symptoms in Mexico, a systematic review: does location matter?
    Pizuorno A; Fierro NA; Copado-Villagrana ED; Herrera-Solís ME; Oskrochi G; Brim H; Ashktorab H
    BMC Infect Dis; 2021 Jun; 21(1):555. PubMed ID: 34116647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk Factors and Clinical Phenotypes Associated with Severity in Patients with COVID-19 in Northeast Mexico.
    García-Alvarado FJ; Muñoz-Hernández MA; Moran Guel E; González-Martínez MDR; Macías Corral MA; Delgado-Aguirre HA
    Vector Borne Zoonotic Dis; 2021 Sep; 21(9):720-726. PubMed ID: 34255563
    [No Abstract]   [Full Text] [Related]  

  • 13. SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.
    Torres-Ibarra L; Basto-Abreu A; Carnalla M; Torres-Alvarez R; Reyes-Sanchez F; Hernández-Ávila JE; Palacio-Mejia LS; Alpuche-Aranda C; Shamah-Levy T; Rivera JA; Barrientos-Gutierrez T
    Int J Epidemiol; 2022 May; 51(2):429-439. PubMed ID: 35157072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe Acute Respiratory Syndrome by SARS-CoV-2 Infection or Other Etiologic Agents Among Brazilian Indigenous Population: An Observational Study from the First Year of Coronavirus Disease (COVID)-19 Pandemic.
    Sansone NMS; Boschiero MN; Ortega MM; Ribeiro IA; Peixoto AO; Mendes RT; Marson FAL
    Lancet Reg Health Am; 2022 Apr; 8():100177. PubMed ID: 35018359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population-Based COVID-19 Screening in Mexico: Assessment of Symptoms and Their Weighting in Predicting SARS-CoV-2 Infection.
    Martinez-Fierro ML; Diaz-Lozano M; Alvarez-Zuñiga C; Ramirez-Hernandez LA; Araujo-Espino R; Trejo-Ortiz PM; Mollinedo-Montaño FE; Ortiz-Castro Y; Vazquez-Reyes S; Velasco-Elizondo P; Garcia-Esquivel L; Araujo-Conejo A; Garza-Veloz I
    Medicina (Kaunas); 2021 Apr; 57(4):. PubMed ID: 33917858
    [No Abstract]   [Full Text] [Related]  

  • 16. Age-related risk factors and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
    Rahman MM; Bhattacharjee B; Farhana Z; Hamiduzzaman M; Chowdhury MAB; Hossain MS; Siddiqee MH; Islam MZ; Raheem E; Uddin MJ
    J Prev Med Hyg; 2021 Jun; 62(2):E329-E371. PubMed ID: 34604574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Clinical Features of Hospitalized Patients Due to the SARS-CoV-2 Infection in the Absence of Comorbidities Regarding the Sex: An Epidemiological Study of the First Year of the Pandemic in Brazil.
    Sansone NMS; Pereira LR; Boschiero MN; Valencise FE; Fraga AMA; Marson FAL
    Int J Environ Res Public Health; 2022 Jul; 19(15):. PubMed ID: 35897265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
    Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
    Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of age on the association between diabetes and mortality in adult patients with COVID-19 in Mexico.
    Woolcott OO; Castilla-Bancayán JP
    Sci Rep; 2021 Apr; 11(1):8386. PubMed ID: 33863997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic and features of SARS-CoV-2 infection in Gabon.
    Mveang Nzoghe A; Padzys GS; Maloupazoa Siawaya AC; Kandet Yattara M; Leboueny M; Avome Houechenou RM; Bongho EC; Mba-Mezeme C; Mvoundza Ndjindji O; Biteghe-Bi-Essone JC; Boulende A; Essone PN; Ndong Sima CAA; Minkobame U; Zang Eyi C; Ndeboko B; Voloc A; Meye JF; Ategbo S; Djoba Siawaya JF
    Sci Rep; 2021 May; 11(1):9672. PubMed ID: 33958601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.